# RIT2

## Overview
RIT2 is a gene that encodes the protein Ras-like without CAAX 2, a member of the Ras superfamily of small GTPases. This protein is predominantly expressed in neural tissues and plays a critical role in various cellular processes, including the regulation of the autophagy-lysosome pathway and dopamine signaling. As a small GTPase, Ras-like without CAAX 2 is involved in modulating mitogen-activated protein kinase (MAPK) pathways, which are essential for cellular signaling related to autophagy and neurite outgrowth. The protein's interaction with the dopamine transporter (DAT) and its involvement in protein kinase C (PKC)-stimulated DAT internalization underscore its importance in maintaining dopaminergic homeostasis. Furthermore, RIT2's interaction with LRRK2, a protein linked to Parkinson's disease, suggests a protective role in neural cells by maintaining lysosomal function and preventing protein aggregation. Genetic variations in RIT2 have been associated with several neurological disorders, including Parkinson's disease, autism, schizophrenia, and bipolar disorder, highlighting its significance in neuropsychiatric health (Obergasteiger2023The; Fagan2020Dopamine; Emamalizadeh2016RIT2).

## Structure


## Function
The RIT2 gene encodes a small GTPase that is primarily expressed in neural tissue and is part of the Ras superfamily of GTPases. In healthy human cells, RIT2 is involved in several critical cellular processes, including the regulation of the autophagy-lysosome pathway (ALP), which is essential for degrading long-lived proteins, defective organelles, and protein aggregates (Obergasteiger2023The). RIT2 modulates the activity of mitogen-activated protein kinases (MAPKs), such as p38 and ERK1/2, which are involved in various signaling pathways related to autophagy (Obergasteiger2023The).

RIT2 also plays a significant role in dopamine (DA) trafficking and the inactivation of the dopamine transporter (DAT), affecting extracellular DA levels and release dynamics. This modulation is linked to locomotor activity, as evidenced by increased locomotion in mice with altered RIT2 expression (Obergasteiger2023The). The protein is crucial for maintaining DAergic homeostasis, as it is necessary for protein kinase C (PKC)-stimulated DAT internalization, which is vital for clearing synaptically released dopamine (Fagan2020Dopamine).

RIT2's interaction with LRRK2, a protein associated with Parkinson's disease, suggests its protective role in maintaining lysosomal function and preventing protein aggregation in neural cells (Obergasteiger2023The).

## Clinical Significance
The RIT2 gene is implicated in several neurological disorders, most notably Parkinson's disease (PD). Genetic alterations in the RIT2 promoter region and specific single-nucleotide polymorphisms (SNPs), such as rs12456492, have been associated with an increased risk of PD. This SNP is also linked to essential tremor (ET) (Emamalizadeh2016RIT2). RIT2 expression is notably reduced in the substantia nigra pars compacta of PD patients, particularly affecting dopamine neurons, which are crucial for motor function (Kearney2023Rit2; Obergasteiger2020RIT2). 

RIT2 overexpression has been shown to reduce LRRK2 kinase activity and protect against alpha-synuclein neuropathology, which are key features of PD pathology. This suggests a potential therapeutic role for RIT2 in modulating these pathways (Obergasteiger2023The; Obergasteiger2020RIT2). Additionally, RIT2 is involved in lysosomal function, and its downregulation can lead to impaired lysosomal activity, contributing to PD pathophysiology (Obergasteiger2023The). 

Beyond PD, RIT2 has been associated with other neurological conditions, including autism, schizophrenia, and bipolar disorder, through different SNPs like rs16976358 (Emamalizadeh2016RIT2). These associations highlight the gene's broader significance in neuropsychiatric disorders.

## Interactions
RIT2, a member of the Ras superfamily of small GTPases, is involved in various protein interactions and multiprotein complexes. It interacts with the dopamine transporter (DAT), playing a crucial role in PKC-stimulated DAT internalization, which affects dopamine signaling in the brain (Fagan2020Dopamine; fagan2020rit2). RIT2 binds to the C-terminal endocytic domain of DAT, and this interaction is necessary for PKC-mediated DAT internalization (fagan2020rit2). The interaction between RIT2 and DAT is modulated by PKC activation, which leads to the dissociation of RIT2 from DAT, facilitating DAT internalization (Fagan2020Dopamine).

RIT2 also interacts with other proteins such as B-Raf, which is involved in activating ERK and p38 MAP kinase pathways necessary for neurite outgrowth (fagan2020rit2). It is involved in the regulation of LRRK2 kinase activity, which is crucial for lysosomal function and protection against alpha-synuclein neuropathology (Obergasteiger2023The). RIT2's interaction with LRRK2 modulates its activity, potentially providing neuroprotective effects against Parkinson's disease (Obergasteiger2023The). These interactions highlight RIT2's significant role in cellular processes related to the nervous system and its involvement in complex signaling pathways.


## References


1. (Kearney2023Rit2) Rit2 silencing in dopamine neurons drives a Parkinsonian phenotype. This article has 0 citations.

[2. (Emamalizadeh2016RIT2) Babak Emamalizadeh, Javad Jamshidi, Abolfazl Movafagh, Mina Ohadi, Mahmoud Shekari khaniani, Somayyeh Kazeminasab, Akbar Biglarian, Shaghayegh Taghavi, Marzieh Motallebi, Atena Fazeli, Azadeh Ahmadifard, Gholam-Ali Shahidi, Peyman Petramfar, Neda Shahmohammadibeni, Tahereh Dadkhah, Ehteram Khademi, Abbas Tafakhori, Ali Khaligh, Tannaz Safaralizadeh, Ali Kowsari, Arash Mirabzadeh, Amir Ehtesham Shafiei Zarneh, Mehdi Khorrami, Parasto Shokraeian, Mohammad Javad Soltani Banavandi, Behnam Safarpour Lima, Monavvar Andarva, Elham Alehabib, Minoo Atakhorrami, and Hossein Darvish. Rit2 polymorphisms: is there a differential association? Molecular Neurobiology, 54(3):2234–2240, March 2016. URL: http://dx.doi.org/10.1007/s12035-016-9815-4, doi:10.1007/s12035-016-9815-4. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-016-9815-4)

3. (Obergasteiger2020RIT2) RIT2 reduces LRRK2 kinase activity and protects against alpha-synuclein neuropathology. This article has 1 citations.

4. (fagan2020rit2) Rit2-Dependent Dopamine Transporter Endocytosis: Intrinsic Mechanism and In Vivo Impact. This article has 0 citations.

[5. (Obergasteiger2023The) Julia Obergasteiger, Anne-Marie Castonguay, Sara Pizzi, Stefano Magnabosco, Giulia Frapporti, Evy Lobbestael, Veerle Baekelandt, Andrew A. Hicks, Peter P. Pramstaller, Claude Gravel, Corrado Corti, Martin Lévesque, and Mattia Volta. The small gtpase rit2 modulates lrrk2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology. npj Parkinson’s Disease, March 2023. URL: http://dx.doi.org/10.1038/s41531-023-00484-2, doi:10.1038/s41531-023-00484-2. This article has 8 citations.](https://doi.org/10.1038/s41531-023-00484-2)

[6. (Fagan2020Dopamine) Rita R. Fagan, Patrick J. Kearney, Carolyn G. Sweeney, Dino Luethi, Florianne E. Schoot Uiterkamp, Klaus Schicker, Brian S. Alejandro, Lauren C. O’Connor, Harald H. Sitte, and Haley E. Melikian. Dopamine transporter trafficking and rit2 gtpase: mechanism of action and in vivo impact. Journal of Biological Chemistry, 295(16):5229–5244, April 2020. URL: http://dx.doi.org/10.1074/jbc.ra120.012628, doi:10.1074/jbc.ra120.012628. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra120.012628)